September 7, 2018

Day and Zindrick enter Aeromics' board of directors

Mark Day and Thomas Zindrick joined the board of directors at Aeromics, a Branford-based clinical-stage pharmaceutical company focused on controlling brain swelling in stroke survivors.

Comments
Free E-Newsletters

Sign up now for our daily and weekly
e-newsletters! Click Here

 
Today's Poll Are apprenticeships a worthwhile workforce-development tool?<>
ADVERTISEMENTS
Most Popular on Facebook
Copyright 2017 New England Business Media